Qtc Nextgen Pharma Llp - Company Profile

It is a business services limited liability partnership based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Qtc Nextgen Pharma Llp

Qtc Nextgen Pharma Llp, a active limited liability partnership, was established on 07 August 2018 in Mumbai, Maharashtra, India. Engaging in other services within the business services sector, it holds LLPIN: AAN-1082. Registered under ROC Roc Mumbai I. It has total obligation of contribution of ₹10.00 K .

Its leadership includes Nikita Jayant Jathar (Designated Partner), Velankani Rajeshwar Lad (Designated Partner). Past directors included Minal Prasad Chaudhari, Waman Tukaram Gawade, Nidhi Jayant Jathar. Its latest date of accounts and solvency statement 31 March 2020. It is based at Flat No.601, Building No. 59, Evershine Millanium Paradise Sector 1, Thakur Village, Kandi, Vali- East, Mumbai, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAN-1082

  • Incorporation Date

    07 August 2018

  • Total Obligation of Contribution

    ₹10.00 K

  • ROC Code

    Roc Mumbai I

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 10.00 K
  • Company Age 7 Year, 9 Months
  • Last Filing with ROC 31 Mar 2020
Company report

Qtc Nextgen Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Qtc Nextgen Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Qtc Nextgen Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Nikita Jayant Jathar Designated Partner 07 Aug 2018 Current
Velankani Rajeshwar Lad Designated Partner 01 Aug 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 13 May 2025 Past
Pramod Abcsdd Designated Partner 13 May 2025 Past
Pramod Abcsdd Designated Partner 01 Aug 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Qtc Nextgen Pharma Llp.

Enhance accessibility to Qtc Nextgen Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Qtc Nextgen Pharma Llp revenue growth over time
Qtc Nextgen Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Qtc Nextgen Pharma Llp?

Unlock access to Qtc Nextgen Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Qtc Nextgen Pharma Llp?

Unlock and access historical data on people associated with Qtc Nextgen Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Qtc Nextgen Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qtc Nextgen Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Qtc Nextgen Pharma Llp
Recent Activity within the Organization
  • Director Appointment

    Velankani Rajeshwar Lad was appointed as a Designated Partner was appointed as a Designated Partner on 01 Aug 2025 & has been associated with this company since 9 months 30 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Qtc Nextgen Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Qtc Nextgen Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai I. was documented.

  • Director Appointment

    Progress on Nikita Jayant Jathar was appointed as a Designated Partner was appointed as a Designated Partner on 07 Aug 2018 & has been associated with this company since 7 years 9 months . was documented.

  • LLP Incorporation

    Qtc Nextgen Pharma Llp was registered on 07 Aug 2018 with Roc Mumbai I & aged 7 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Qtc Nextgen Pharma Llp?

The LLPIN of Qtc Nextgen Pharma Llp is AAN-1082.

Where is Qtc Nextgen Pharma Llp headquartered?

Qtc Nextgen Pharma Llp is headquartered at Flat No.601, Building No. 59, Evershine Millanium Paradise Sector 1, Thakur Village, Kandi, Vali- East, Mumbai, Maharashtra, 400101.

When was Qtc Nextgen Pharma Llp incorporated?

Qtc Nextgen Pharma Llp was incorporated on 07 August 2018.

Who are the current directors of Qtc Nextgen Pharma Llp?

The current directors of Qtc Nextgen Pharma Llp are

What is the primary industry of Qtc Nextgen Pharma Llp?

The primary industry of Qtc Nextgen Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available